Ionis Pharmaceuticals, Inc. (IONS)
43.54
-0.46
(-1.05%)
USD |
NASDAQ |
Oct 02, 16:00
43.60
+0.06
(+0.14%)
After-Hours: 20:00
Ionis Pharmaceuticals Profit Margin (Quarterly) : -42.79% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -42.79% |
| March 31, 2026 | -37.60% |
| December 31, 2025 | -112.8% |
| September 30, 2025 | -82.06% |
| June 30, 2025 | 27.33% |
| March 31, 2025 | -111.6% |
| December 31, 2024 | -45.82% |
| September 30, 2024 | -105.0% |
| June 30, 2024 | -29.42% |
| March 31, 2024 | -119.5% |
| December 31, 2023 | -2.77% |
| September 30, 2023 | -102.2% |
| June 30, 2023 | -45.27% |
| March 31, 2023 | -95.25% |
| December 31, 2022 | -34.21% |
| September 30, 2022 | -29.41% |
| June 30, 2022 | -78.58% |
| March 31, 2022 | -45.92% |
| December 31, 2021 | 51.07% |
| September 30, 2021 | -61.96% |
| June 30, 2021 | -64.31% |
| March 31, 2021 | -80.52% |
| December 31, 2020 | -122.8% |
| September 30, 2020 | -22.87% |
| June 30, 2020 | -25.81% |
| Date | Value |
|---|---|
| March 31, 2020 | -37.40% |
| December 31, 2019 | 41.19% |
| September 30, 2019 | 10.98% |
| June 30, 2019 | -6.15% |
| March 31, 2019 | 31.62% |
| December 31, 2018 | |
| September 30, 2018 | -14.01% |
| June 30, 2018 | -48.05% |
| March 31, 2018 | -7.49% |
| December 31, 2017 | -2.25% |
| September 30, 2017 | -6.33% |
| June 30, 2017 | -2.75% |
| March 31, 2017 | 7.74% |
| December 31, 2016 | 16.13% |
| September 30, 2016 | 6.63% |
| June 30, 2016 | -147.8% |
| March 31, 2016 | -170.6% |
| December 31, 2015 | -138.5% |
| September 30, 2015 | -72.83% |
| June 30, 2015 | 29.60% |
| March 31, 2015 | -26.71% |
| December 31, 2014 | 36.59% |
| September 30, 2014 | -60.54% |
| June 30, 2014 | -21.17% |
| March 31, 2014 | -111.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Biogen, Inc. | 3.72% |
| BridgeBio Pharma, Inc. | -63.97% |
| Vertex Pharmaceuticals, Inc. | 32.89% |
| Pfizer Inc. | -1.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -105.8% |
| Return on Assets | -17.66% |
| Return on Invested Capital | -20.02% |
| Gross Profit Margin (Quarterly) | 96.13% |
| Operating Margin (Quarterly) | -38.18% |
| Return on Net Operating Assets | -133.8% |